Remedium Bio

Remedium Bio is a preclinical-stage biotechnology company dedicated to developing novel gene therapies to treat various severely debilitating diseases. The company's R&D approach focuses on modularly combining mature technologies to address well-characterized disease pathologies, thereby streamlining the product development process. Remedium Bio's pipeline includes a leading first-in-class single-injection gene therapy candidate for osteoarthritis, as well as gene therapies for diabetes and stroke.